Drug side effects
sumatriptan Side Effects
The reactions most often reported to the FDA for sumatriptan (also sold as Imitrex), with demographics, serious outcomes, and reporting trends.
Data updated 2026-05-15
- 36,885
- FAERS reports
Data from the FDA Adverse Event Reporting System (FAERS), 1996 to 2025. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.
The most commonly reported side effects of sumatriptan come from 36,885 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.
This page analyzes 36,885 reports to the FDA Adverse Event Reporting System (FAERS) for sumatriptan (Imitrex): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.
Total Reports
36,885
Reports Mentioning Death
865
2.3% of reports — not proof the medicine caused the death
Hospitalizations
6,843
18.6% of reports
Top Indication
Migraine
Most Reported Adverse Reactions
Who Reports Side Effects
Gender Distribution
Age Distribution
Reporting Trend by Year
Reactions in Death Reports
Top reactions reported in 865 reports where death was an outcome. These are voluntarily reported and do not establish causation.
| Reaction | Reports |
|---|---|
| DEATH | 259 |
| COMPLETED SUICIDE | 136 |
| TOXICITY TO VARIOUS AGENTS | 99 |
| CARDIAC ARREST | 73 |
| VOMITING | 35 |
| HEADACHE | 33 |
| PAIN | 33 |
| DYSPNOEA | 32 |
| RESPIRATORY FAILURE | 30 |
| PNEUMONIA | 28 |
| RENAL FAILURE | 28 |
| FALL | 27 |
| MALAISE | 26 |
| ACUTE KIDNEY INJURY | 25 |
| LOSS OF CONSCIOUSNESS | 25 |
| OVERDOSE | 25 |
| FATIGUE | 23 |
| NAUSEA | 23 |
| ASTHENIA | 22 |
| CARDIO-RESPIRATORY ARREST | 21 |
Reactions in Hospitalization Reports
Top reactions in 6,843 reports where hospitalization was an outcome.
| Reaction | Reports |
|---|---|
| HEADACHE | 649 |
| NAUSEA | 614 |
| PAIN | 614 |
| MIGRAINE | 566 |
| VOMITING | 472 |
| FATIGUE | 442 |
| DYSPNOEA | 428 |
| ANXIETY | 377 |
| DIZZINESS | 377 |
| CHEST PAIN | 353 |
| FALL | 339 |
| DEPRESSION | 336 |
| DIARRHOEA | 334 |
| PNEUMONIA | 333 |
| PULMONARY EMBOLISM | 318 |
| ABDOMINAL PAIN | 292 |
| ASTHENIA | 276 |
| PYREXIA | 270 |
Nearby, Related Medications
What the FAERS Data Reveals About sumatriptan Side Effects
The FDA Adverse Event Reporting System (FAERS) contains 36,885 voluntary reports linked to sumatriptan and its brand equivalents (Imitrex), spanning 1996 through 2025. Of those, 865 (2.3%) listed death as an outcome and 6,843 (18.6%) involved hospitalization. The most common indication reported alongside adverse events was Migraine.
Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 85% were female and 15% male; age distribution skews toward 45-64, with 10,117 reports in that bracket. The single most reported reaction is headache with 3,102 submissions, followed by nausea and migraine.
How to read these numbers
FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.
Drugs With a Similar FAERS Report Volume
Other medications with a total FDA adverse-event report count closest to sumatriptan's 36,885.
Read our methodology - how this data is sourced, computed, and verified.